New England Journal of Medicine is publishing two studies this Sunday, Dec. 10, on CAR T-cell therapy. Dr. David Maloney, who heads Fred Hutch's clinical immunotherapy research, is not a co-author but is familiar with both of the trials. If you're seeking an expert source to discuss their significance and provide perspective, he's available Friday evening (12/08) and all day Saturday. 

MEDIA CONTACT
Register for reporter access to contact details
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Cancer Cell Biology Immunology
KEYWORDS
CAR T cell therapy immunotoherapy NEJM axicabtagene ciloleucel Chimeric antigen receptor T-cell Large B Cell Lymphoma B-Cell Lymphoma
COMMENTS | COMMENTING POLICY